FDA Accepts Valneva’s Chikungunya Vaccine License Application for Priority Review
NewsDeskactiman63 The specialty vaccine company, Valneva, announced that the U.S. Food and Drug Administration (FDA) has completed a submission review of its biologics authorization application for Valneva’s VLA1553 one-shot chikungunya vaccine candidate and determined that the application is sufficiently complete to allow objective review. Review rating is priority. A prescription was assigned to VLA1553 […]
the post The US Food and Drug Administration accepts Valneva’s chikungunya vaccine authorization application for priority review Debuted Breaking news today.